JP Morgan Chase
RKDA icon

JP Morgan Chase’s Arcadia Biosciences RKDA Stock Holding History

JP Morgan Chase’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-508
Closed -$1.54K – 7813
2023
Q4 		$1.54K Buy
+508
New +$1.59K ﹤0.01% 6764
2020
Q4 		– Hold
0
– – – 5885
2020
Q3 		– Hold
0
– – – 5724
2020
Q2 		– Hold
0
– – – 5649

Other funds holding RKDA

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
OLVIG
Oliver Lagore Vanvalin Investment Group Flint, Michigan $255M AUM

JP Morgan Chase's RKDA Position: Q1 2024 in Review

JP Morgan Chase sold out of Arcadia Biosciences (RKDA) in Q1 2024, closing a stake of 508 shares — an estimated $1.54K sold.

JP Morgan Chase first reported a position in RKDA in Q4 2023 and held it in 1 quarter. The position peaked at $1.54K in Q4 2023. 14 funds tracked by Wall St. Rank hold RKDA as of Q1 2024.

  • JP Morgan Chase reported no remaining Arcadia Biosciences position as of Q1 2024 after selling out during the quarter.
  • JP Morgan Chase sold 508 Arcadia Biosciences shares in Q1 2024, an estimated $1.54K.
  • JP Morgan Chase first reported a position in Arcadia Biosciences in Q4 2023 and held it in 1 quarter.
  • JP Morgan Chase's Arcadia Biosciences position peaked at $1.54K in Q4 2023.
  • 14 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.